The completion of the Phase II expansion will double the capacity of the pallet warehouse at room temperature of 15°C to 30°C
AMHERST, NH, November 22, 2022 /PRNewswire/ — Alcami, a leading contract engineering and manufacturing company (CDMO), today announced the completion of Phase II of its cGMP biostorage facility Amherst, New Hampshire.
“The successful timely completion of the second phase of this project will double our biostorage capacity in New Hampshire to approximately 14,000 pallet locations with world-class cGMP storage capacity to support customer demand,” he commented Timothy ComptonChief Business Officer at Alcami.
located in Amherst, NH, The 160,000 sq ft facility features state-of-the-art infrastructure and systems. With the completion of Phase II, 104,000 ft² is now fully operational and ready to support a variety of cGMP customer storage requirements. Phase III is scheduled for completion in the first quarter of 2023 and will add an additional 56,000 sq ft of new capacity.
“This investment reinforces our commitment to our pharmaceutical customers in support of their increasing demand for safe and reliable cGMP storage requirements.” Added Mr. Compton.
Masy BioServices, acquired by Alcami in 2021, provides cGMP temperature storage from ≤ -135°C to 70°C, including all ICH stability conditions, for vaccines, biopharmaceuticals, cell banks, tissues, pharmaceutical compounds, raw materials, components and medical devices .
Alcami is a contract design and manufacturing company headquartered in North Carolina with over 40 years of experience in advancing products through all phases of the development life cycle. With 675,000 sq ft across five US science campuses, Alcami serves pharmaceutical and biotechnology companies of all sizes, providing customizable and innovative solutions for analytical development, clinical to commercial sterile and oral solids manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring and pharmacy Support Services. Alcami’s private equity properties include GHO Capital, The Vistria Group and Ampersand Capital Partners. Visit alcaminow.com for more information.
SOURCE Alcami Corporation